iTeos Therapeutics, Inc. (ITOS)
Latest ITOS Insider Trades
About iTeos Therapeutics, Inc. (ITOS)
iTeos Therapeutics, Inc. is an SEC registrant, filing under CIK 0001808865, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
90-Day SEC Filing Activity
No Form 4 activity for ITOS in the last 90 days.
ITOS Insider Transactions (Form 4)
3612 Form 4 filings on record, the earliest from Nov 20, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Ann D. Rhoads | Derivative | Stock Option (Right to Buy) | 27,178 |
ITOS Insider Trading - FAQ
What is the latest insider trade for ITOS?
iTeos Therapeutics, Inc. (ITOS) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-08-29. The full record for ITOS runs to 12 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ITOS stock?
No insider purchases of ITOS were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling ITOS stock?
No insider sales of ITOS were filed in the last 90 days. 2 sales are on record for this company.
Where can I see ITOS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ITOS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ITOS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ITOS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Ann D. Rhoads view on EDGAR
- - David Hallal view on EDGAR
- - David K. Lee view on EDGAR
- - Michel Detheux view on EDGAR
- - Matthew Call view on EDGAR
- - David Feltquate view on EDGAR
- - Matthew Gall view on EDGAR
- - Yvonne McGrath view on EDGAR
- - Ansbert Gadicke view on EDGAR
- - MPM BioVentures 2014, L.P. view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ITOS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ITOS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
